Even after controlling for a person’s existing substance use and mental health disorders, there remained a 3.5-fold increased ...

A new study is shedding light on the complex brain connectivity changes induced by three psychoactive substances: lysergic ...

Study links hallucinogen use to higher schizophrenia risk, highlighting the need for caution and informed decisions on ...

Psychedelics still have potential as PTSD therapies, Smyth said, who added that the VA is continuing to encourage study of MDMA and other psychedelic agents. The VA issued a call for proposals for ...

The 90-subject study found that after three MDMA-assisted therapy sessions, 67% of participants with PTSD no longer qualified for that diagnosis, while 88% experienced a significant reduction in ...

Interestingly, the study also suggests that psychedelics may enhance creativity and executive function after their immediate effects have worn off—an effect not observed with MDMA. This finding ...

Individuals with emergency department visits involving hallucinogen use are at high risk of developing schizophrenia, ...

MDMA-assisted psychotherapy (MAP ... combined with preparatory and integration sessions, led to 71 percent of study participants no longer meeting diagnostic criteria for PTSD.

The United States Food and Drug Administration cleared the investigational new drug application for VLS-01 (buccal film DMT); atai expects to ...